Target Bioconjugation of Protein Through Chemical, Molecular Dynamics, and Artificial Intelligence Approaches

Metabolites. 2024 Dec 2;14(12):668. doi: 10.3390/metabo14120668.

Abstract

Covalent modification of proteins at specific, predetermined sites is essential for advancing biological and biopharmaceutical applications. Site-selective labeling techniques for protein modification allow us to effectively track biological function, intracellular dynamics, and localization. Despite numerous reports on modifying target proteins with functional chemical probes, unique organic reactions that achieve site-selective integration without compromising native functional properties remain a significant challenge. In this review, we delve into site-selective protein modification using synthetic probes, highlighting both chemical and computational methodologies for chemo- and regioselective modifications of naturally occurring amino acids, as well as proximity-driven protein-selective chemical modifications. We also underline recent traceless affinity labeling strategies that involve exchange/cleavage reactions and catalyst tethering modifications. The rapid development of computational infrastructure and methods has made the bioconjugation of proteins more accessible, enabling precise predictions of structural changes due to protein modifications. Hence, we discuss bioconjugational computational approaches, including molecular dynamics and artificial intelligence, underscoring their potential applications in enhancing our understanding of cellular biology and addressing current challenges in the field.

Keywords: bioconjugation; computational method; protein modification.

Publication types

  • Review

Grants and funding

This work received financial support from the National Science and Technology Council (NSTC), Taiwan, grant number: NSTC 112-2811-B-039-021, NSTC 113-2811-B-468-003, NSTC 112-2320-B-039-005, NSTC 113-2320-B-039-002, NSTC 113-2320-B-039-061-MY3, and MOST 111-2314-B-039-062-MY3; the National Health Research Institute, Taiwan, grant number NHRI-EX113-11110BI; the China Medical University/Hospital, Taiwan, grant number DMR-111-118 and DMR-112-098; and the Asia University Hospital, Taiwan, AUH-11251003 and AUH-11351001. The APC was funded by NSTC 111-2314-B-468-012-MY3.